(2019) musculoskeletal healing WADA Status: Research compound (verify current prohibited list) BIONIX BPC-157 is supplied exclusively for laboratory research purposesnot for therapeutic use, human administration, veterinary, or clinical applications
Who We Work With Our coordination services are available exclusively to: Licensed physicians, NPs, and PAs operating within their state scope of practice Medical weight management clinics and bariatric practices Integrative and functional medicine practices Hospital outpatient programs and group practices Aesthetic and wellness clinics under qualified medical direction We do not work with consumers, or entities seeking product for resale outside a licensed clinical setting
Women have reported longer, heavier, irregular periods and, in some cases, breakthrough bleeding in postmenopausal women
Must be handled by qualified research professionals
Key Research Points at a Glance A 15-amino-acid fragment of a gastric-juice-derived protective protein, first characterised in the early 1990s Primary research mechanisms: angiogenesis (VEGF pathway) and gastric/gut-lining signalling Secondary mechanisms under study: growth factor modulation (EGF, FGF) and nitric oxide system interaction Frequently co-researched with TB-500 despite acting through an unrelated mechanism The large majority of published research is pre-clinical (in-vitro and animal-model), not human clinical data Notably stable across a wider pH/temperature range than many comparable research peptides What Is BPC-157
A minimum of 55.7 million reads were obtained for all samples (Extended Data Fig
